Development of a Chemiluminescence Immunoassay for Serum YB-1 and its Clinical Application as a Potential Diagnostic Marker for Hepatocellular Carcinoma.
about
Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases.Distribution of breast density in Iranian women and its association with breast cancer risk factorsAccuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review)
P2860
Development of a Chemiluminescence Immunoassay for Serum YB-1 and its Clinical Application as a Potential Diagnostic Marker for Hepatocellular Carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of a Chemiluminesc ...... for Hepatocellular Carcinoma.
@en
Development of a Chemiluminesc ...... for Hepatocellular Carcinoma.
@nl
type
label
Development of a Chemiluminesc ...... for Hepatocellular Carcinoma.
@en
Development of a Chemiluminesc ...... for Hepatocellular Carcinoma.
@nl
prefLabel
Development of a Chemiluminesc ...... for Hepatocellular Carcinoma.
@en
Development of a Chemiluminesc ...... for Hepatocellular Carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Development of a Chemiluminesc ...... for Hepatocellular Carcinoma.
@en
P2093
Cheng Feng
Dong Jinyu
Guo Bianqin
Kuang Wenbin
Liang Qindong
Liu Chenggui
P2860
P356
10.5812/HEPATMON.8918
P407
P577
2013-07-03T00:00:00Z